SE7811446L - Infusionslosning for behandling av hepatisk encefalopati - Google Patents

Infusionslosning for behandling av hepatisk encefalopati

Info

Publication number
SE7811446L
SE7811446L SE7811446A SE7811446A SE7811446L SE 7811446 L SE7811446 L SE 7811446L SE 7811446 A SE7811446 A SE 7811446A SE 7811446 A SE7811446 A SE 7811446A SE 7811446 L SE7811446 L SE 7811446L
Authority
SE
Sweden
Prior art keywords
treatment
infusion solution
hepatic encephalopathy
encephalopathy
hepatic
Prior art date
Application number
SE7811446A
Other languages
English (en)
Swedish (sv)
Inventor
G Kleinberger
Original Assignee
Leopold & Co Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leopold & Co Chem Pharm filed Critical Leopold & Co Chem Pharm
Publication of SE7811446L publication Critical patent/SE7811446L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7811446A 1977-11-09 1978-11-06 Infusionslosning for behandling av hepatisk encefalopati SE7811446L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2750159A DE2750159C3 (de) 1977-11-09 1977-11-09 Infusionslösung zur Behandlung von hepatischer Encephalopathie und ein Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
SE7811446L true SE7811446L (sv) 1979-05-10

Family

ID=6023374

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7811446A SE7811446L (sv) 1977-11-09 1978-11-06 Infusionslosning for behandling av hepatisk encefalopati

Country Status (11)

Country Link
US (1) US4259353A (de)
JP (1) JPS5489014A (de)
BE (1) BE871860A (de)
CA (1) CA1103160A (de)
CH (1) CH636766A5 (de)
DE (1) DE2750159C3 (de)
FR (1) FR2408347A1 (de)
GB (1) GB2007503B (de)
IT (1) IT1108758B (de)
NL (1) NL7810654A (de)
SE (1) SE7811446L (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1184499A (en) * 1981-06-29 1985-03-26 David C. Madsen Nutritional composition for management of hepatic failure
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
WO1996000059A1 (fr) * 1994-06-23 1996-01-04 Chugai Seiyaku Kabushiki Kaisha Agent therapeutique de regenerescence hepatique
US20040022827A1 (en) * 1997-09-30 2004-02-05 Chugai Seiyaku Kabusiki Kaisha Remedy for hepatopathy
WO2010011927A1 (en) 2008-07-25 2010-01-28 Noventis, Inc. Compositions and methods for the prevention and treatment of cardiovascular diseases
AU2011280985C1 (en) 2010-07-22 2016-04-21 Reven Pharmaceuticals, Inc. Methods of treating or ameliorating diseases and enhancing performance comprising the use of a magnetic dipole stabilized solution
JP7142284B2 (ja) * 2017-06-06 2022-09-27 株式会社らいむ 神経伸長促進剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146166A (en) * 1960-08-26 1964-08-25 Distillers Co Yeast Ltd Cobalamin and amino acid compositions
DK98833C (da) * 1961-04-25 1964-05-25 Novo Terapeutisk Labor As Fremgangsmåde til stabilisering af terapeutisk anvendelige plasminopløsninger.
US3764703A (en) * 1969-11-07 1973-10-09 Astra Ab Amino acid mixture for use in treatment of uremic conditions
US3832465A (en) * 1971-12-09 1974-08-27 H Ghadimi Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
DE2629845A1 (de) * 1976-07-02 1978-01-05 Geb Graze Erika Graze Infusions- bzw. injektionsloesungen bzw. waessrige konzentrate zu deren bereitung zur therapeutischen restituion des zellulaeren energiestoffwechsels und der koerpereigenen regelfunktion

Also Published As

Publication number Publication date
BE871860A (fr) 1979-05-08
FR2408347B1 (de) 1981-06-26
IT7869444A0 (it) 1978-10-24
GB2007503B (en) 1982-03-17
DE2750159A1 (de) 1979-05-10
CA1103160A (en) 1981-06-16
NL7810654A (nl) 1979-05-11
GB2007503A (en) 1979-05-23
IT1108758B (it) 1985-12-09
CH636766A5 (de) 1983-06-30
JPS5729446B2 (de) 1982-06-23
DE2750159C3 (de) 1980-05-22
US4259353A (en) 1981-03-31
DE2750159B2 (de) 1979-09-06
FR2408347A1 (fr) 1979-06-08
JPS5489014A (en) 1979-07-14

Similar Documents

Publication Publication Date Title
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO782127L (no) Fremgangsmaate for fremstilling av fysiologisk aktive isoksazolo-pyridin-derivater
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
SE7804839L (sv) Forfarande for framstellning av urea
SE7807852L (sv) Forfarande for sterilisering av blodpulver
FI783198A (fi) Vaetskespridare foer en eldslaeckningsanordning
DK148408C (da) Medicinsk klaebemiddel
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
FI781330A (fi) Foerbaettrad begraensare foer medelstroemmaengden av en straole
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
IT1105232B (it) Procedimento per il trattamento di materie termosensibili
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
FI772319A (fi) Anordning foer orientering av med bindemedel foersedda lignocellulosahaltiga delar
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
FI56113B (fi) Anordning foer lyftning av en saengbunden patient
SE7811446L (sv) Infusionslosning for behandling av hepatisk encefalopati
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
AR211570A1 (es) Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo
SE7800933L (sv) Forfarande for framstellning av 3-metylpyridin
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
NO145656C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyletanolaminderivater
SE7804545L (sv) Forfarande for behandling av cereala plantor
SE7805324L (sv) Forfarande for framstellning av 3-bromftalid